InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-4.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Coyne Terrance P., Chief Financial Officer. Insider active across 1 company, notably Royalty Pharma plc. In total, 9 filings have been logged. Split: 0 buy · 6 sells. Total volume traded: €7.6m. Activity tracked since 7 May 2021. The latest transaction was disclosed on 26 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
64,399 shares@ US$53.97780.0098% mcap39.1% of flowClass A Ordinary SharesSEC:0001814876-26-000022:0
48,646 shares0Class A Ordinary SharesSEC:0001802768-25-000033:0
37,500 shares@ US$30.718313.7% of flowClass A Ordinary SharesSEC:0001209191-23-045463:0
37,500 shares@ US$31.073513.7% of flowClass A Ordinary SharesSEC:0001209191-23-042297:0
24,500 shares@ US$43.469913.9% of flowClass A Ordinary SharesSEC:0001209191-22-056420:0
5,500 shares@ US$43.06293.1% of flowClass A Ordinary SharesSEC:0001209191-22-055873:0
30,000 shares@ US$43.190916.5% of flowClass A Ordinary SharesSEC:0000899243-22-027643:0
1,000,000 shares0Class A Ordinary SharesSEC:0000950103-21-007077
1,000,000 shares0Class A Ordinary SharesSEC:0000950103-21-007077:0
9 of 9 declarations
About Coyne Terrance P.
Terrance P. Coyne is the Executive Vice President and Chief Financial Officer at Royalty Pharma plc. He is responsible for financial management and budgeting strategy for the company. His role is crucial in ensuring the financial health and growth of the organization.
